Sigma Planning Corp Sells 190 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Sigma Planning Corp cut its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,261 shares of the medical research company’s stock after selling 190 shares during the quarter. Sigma Planning Corp’s holdings in Thermo Fisher Scientific were worth $1,252,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its holdings in shares of Thermo Fisher Scientific by 0.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,706,326 shares of the medical research company’s stock valued at $605,651,000 after purchasing an additional 17,860 shares during the last quarter. BTIM Corp. purchased a new position in Thermo Fisher Scientific in the 1st quarter worth approximately $279,000. Meeder Asset Management Inc. raised its holdings in Thermo Fisher Scientific by 73.2% in the 1st quarter. Meeder Asset Management Inc. now owns 1,237 shares of the medical research company’s stock worth $338,000 after acquiring an additional 523 shares during the last quarter. Cohen Lawrence B raised its holdings in Thermo Fisher Scientific by 1.7% in the 1st quarter. Cohen Lawrence B now owns 9,990 shares of the medical research company’s stock worth $2,734,000 after acquiring an additional 169 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in Thermo Fisher Scientific in the 1st quarter worth approximately $96,000. 88.21% of the stock is currently owned by institutional investors.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 275 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $270.73, for a total value of $74,450.75. Following the completion of the sale, the director now owns 6,433 shares of the company’s stock, valued at approximately $1,741,606.09. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the completion of the sale, the chief executive officer now directly owns 342,193 shares of the company’s stock, valued at approximately $97,466,832.19. The disclosure for this sale can be found here. In the last ninety days, insiders sold 52,775 shares of company stock valued at $14,986,676. 0.45% of the stock is currently owned by insiders.

NYSE:TMO traded up $2.84 during trading hours on Friday, reaching $276.15. The company had a trading volume of 992,900 shares, compared to its average volume of 1,602,729. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.58. Thermo Fisher Scientific Inc. has a 52 week low of $208.34 and a 52 week high of $305.45. The firm has a market cap of $109.45 billion, a price-to-earnings ratio of 24.83, a PEG ratio of 1.79 and a beta of 1.11. The firm’s 50 day moving average price is $286.98 and its 200-day moving average price is $272.14.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 24th. The medical research company reported $3.04 EPS for the quarter, topping analysts’ consensus estimates of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The business had revenue of $6.32 billion during the quarter, compared to the consensus estimate of $6.31 billion. During the same quarter in the previous year, the firm posted $2.75 EPS. The firm’s revenue was up 3.9% on a year-over-year basis. On average, analysts forecast that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 6.83%.

TMO has been the subject of a number of recent analyst reports. Credit Suisse Group restated a “buy” rating and issued a $310.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, July 31st. UBS Group boosted their price objective on shares of Thermo Fisher Scientific from $305.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, May 23rd. Barclays set a $330.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Monday, July 15th. Needham & Company LLC boosted their price objective on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a report on Thursday, July 25th. Finally, Argus boosted their price objective on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $303.17.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: Catch-Up Contributions

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.